BIOKE and Fluidigm Announce Exclusive Distribution Agreement
News Aug 06, 2007
The Fluidigm says that the BioMark system provides orders-of-magnitude increase in throughput compared to conventional RT-PCR and genotyping platforms, at a fraction of the labor and running cost. This breakthrough is possible because the BioMark system reads dynamic arrays – nanofluidic chips that contain preprogrammed fluidic networks that automatically combine sets of samples with sets of PCR assays.
BioMark dynamic arrays can provide a high-throughput and means to validate gene- or SNP-based biomarkers by PCR. An array generates 2,304 PCR assays, yet it requires only 96 pipetting steps (input of 48 off-the-shelf primer-probe sets and 48 samples), or 1/40 the pipetting steps required by 384-well systems.
New Cell-weighing Technique Helps Predict How Drugs Affect Cancer CellsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE